People living with HIV or AIDS

The COVID-19 pandemic has changed many things about the way we live our lives. Researchers all over the world have been trying to find reliable information about this new virus.

The National Department of Health is introducing a new drug, Dolutegravir (DTG), in combination with Tenofovir (TDF) and Lamivudine (3TC). The combination of TDF/3TC/DTG is known as TLD. The objectives of this training are to:

Introduction: 

In South Africa, evidence shows high HIV prevalence in older populations, with sexual behavior consistent with high HIV acquisition and transmission risk. However, there is a dearth of evidence on older people's HIV incidence.

Introduction

Introduction

Introduction

Person‐centered care through integration of services and engaging clients in their own care is essential to achieving epidemic control of HIV. Verticalization of services along the care continuum contributes to inequities in access to care and leads to stigma and discrimination.

Background

UNAIDS study shows that the impact on production and logistics caused by COVID-19 could have a significant effect on antiretroviral therapy supply worldwide, but steps taken now could lessen the damage done